As an exploratory aim, we applied a novel z‐score model for plasma GFAP to define biomarker profiles reflecting AD pathology, neuronal injury, and neuroinflammation (p‐tau217/NfL/GFAP). This evidence concerns the gene GFAP and Alzheimer disease.